Search Results - "Rossignol, Patrick"

Refine Results
  1. 1

    Cardiorenal Syndrome Revisited by Zannad, Faiez, Rossignol, Patrick

    Published in Circulation (New York, N.Y.) (28-08-2018)
    “…Cardiorenal syndromes have been categorized into 5 clinical subtypes based on which organ is perceived to be the primary precipitant of the vicious and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure by Coiro, Stefano, Rossignol, Patrick, Ambrosio, Giuseppe, Carluccio, Erberto, Alunni, Gianfranco, Murrone, Adriano, Tritto, Isabella, Zannad, Faiez, Girerd, Nicolas

    Published in European journal of heart failure (01-11-2015)
    “…Aims Residual pulmonary congestion at discharge is associated with poor prognosis in heart failure (HF), but its quantification through physical examination is…”
    Get full text
    Journal Article
  5. 5

    Abnormalities of Potassium in Heart Failure by Ferreira, João Pedro, Butler, Javed, Rossignol, Patrick, Pitt, Bertram, Anker, Stefan D., Kosiborod, Mikhail, Lund, Lars H., Bakris, George L., Weir, Matthew R., Zannad, Faiez

    “…Potassium (K+) is the most abundant cation in humans and is essential for normal cellular function. Alterations in K+ regulation can lead to neuromuscular,…”
    Get full text
    Journal Article
  6. 6

    Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis by Calvier, Laurent, Miana, Maria, Reboul, Pascal, Cachofeiro, Victoria, Martinez-Martinez, Ernesto, de Boer, Rudolf A, Poirier, Françoise, Lacolley, Patrick, Zannad, Faiez, Rossignol, Patrick, López-Andrés, Natalia

    “…OBJECTIVE—Aldosterone (Aldo) is involved in arterial stiffness and heart failure, but the mechanisms have remained unclear. Galectin-3 (Gal-3), a…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Prognostic Value of Estimated Plasma Volume in Heart Failure by Duarte, Kévin, MSc, Monnez, Jean-Marie, PhD, Albuisson, Eliane, MD, PhD, Pitt, Bertram, MD, Zannad, Faiez, MD, PhD, Rossignol, Patrick, MD, PhD

    Published in JACC. Heart failure (01-11-2015)
    “…Abstract Objectives The purpose of this study was to assess the prognostic value of the estimation of plasma volume or of its variation beyond clinical…”
    Get full text
    Journal Article
  10. 10

    Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure by Vardeny, Orly, PharmD, MS, Wu, Dong Hong, PhD, Desai, Akshay, MD, MPH, Rossignol, Patrick, MD, Zannad, Faiez, MD, Pitt, Bertram, MD, Solomon, Scott D., MD

    “…Objectives This study investigated the influence of baseline and worsening renal function (WRF) on the efficacy of spironolactone in patients with severe heart…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Geographic differences in heart failure trials by Ferreira, João Pedro, Girerd, Nicolas, Rossignol, Patrick, Zannad, Faiez

    Published in European journal of heart failure (01-09-2015)
    “…Randomized controlled trials (RCTs) are essential to develop advances in heart failure (HF). The need for increasing numbers of patients (without substantial…”
    Get full text
    Journal Article
  14. 14

    Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage by Martinez-Martinez, Ernesto, Ibarrola, Jaime, Calvier, Laurent, Fernandez-Celis, Amaya, Leroy, Celine, Cachofeiro, Victoria, Rossignol, Patrick, Lopez-Andres, Natalia

    Published in PloS one (09-11-2016)
    “…Galectin-3 (Gal-3), a β-galactoside-binding lectin, is increased in kidney injury and its pharmacological blockade reduces renal damage in acute kidney injury,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Management of hyperkalemia in the acutely ill patient by Dépret, François, Peacock, W. Frank, Liu, Kathleen D., Rafique, Zubaid, Rossignol, Patrick, Legrand, Matthieu

    Published in Annals of intensive care (28-02-2019)
    “…Purpose To review the mechanisms of action, expected efficacy and side effects of strategies to control hyperkalemia in acutely ill patients. Methods We…”
    Get full text
    Journal Article
  20. 20

    Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials by Rossello, Xavier, Ferreira, João Pedro, Pocock, Stuart J., McMurray, John J.V., Solomon, Scott D., Lam, Carolyn S.P., Girerd, Nicolas, Pitt, Bertram, Rossignol, Patrick, Zannad, Faiez

    Published in European journal of heart failure (01-05-2020)
    “…Aims Women with heart failure (HF) are under‐represented in individual randomized clinical trials (RCTs). Little is known about sex‐specific treatment effects…”
    Get full text
    Journal Article